Evidence map›Paper›PMID 41549468›Full record

ArticleJournal of leukocyte biology2026

Basal activation of ERK1/2 blunts the antimicrobial activity of neutrophils from old hosts against antibody-opsonized Streptococcus pneumoniae.

Shaunna R Simmons, Annabel Rivera, Elsa N Bou Ghanem

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Shaunna R SimmonsDepartment of Microbiology and Immunology, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, 955 Main Street, Buffalo, NY 14203, United States.
Annabel RiveraDepartment of Microbiology and Immunology, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, 955 Main Street, Buffalo, NY 14203, United States.
Elsa N Bou GhanemDepartment of Microbiology and Immunology, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, 955 Main Street, Buffalo, NY 14203, United States.ORCID 0000-0002-8936-1341

Funding

The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responsesR01AG068568 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BOU GHANEM, ELSA · 2021 to 2025
$2.0M
The role of A1 adenosine receptor signaling in the decline of S. pneumoniae killing by neutrophils in vaccinated aged hostsF31AI169889 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SIMMONS, SHAUNNA · 2023 to 2025
$83k
National Institute of Health F31AI169889-01A1National Institute of Health R01AG068568-01A1NIAID NIH HHS F31 AI169889NIA NIH HHS R01 AG068568
6 · The paper itself

Abstract

Age-related decline in neutrophil function reduces vaccine protection against Streptococcus pneumoniae. In vaccinated hosts, neutrophil activation via complement and Fcγ receptors mediates bacterial uptake and killing. Mechanisms behind age-related changes in signaling of these receptors is unknown. Using neutrophils from young and old mice, we found opsonin-dependent differences in mitogen-activated protein kinase (MAPK) activation. Neutrophils from old mice had higher basal phosphorylation of MAPK proteins than those of young control mice, including a 15-fold increase in phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2), but did not increase phosphorylation upon infection with antibody-opsonized bacteria. Inhibition of ERK1/2 signaling blunted killing of antibody-opsonized pneumococci by neutrophils from young mice but improved killing in old mice. In young adult human participants, inhibition of ERK1/2 signaling in neutrophils decreased pneumococcal killing, but only in vaccinated hosts, demonstrating the clinical relevance of this pathway. This study demonstrates that balanced activation of ERK1/2 is crucial for neutrophil antimicrobial activity against antibody-opsonized bacteria but is disrupted in old hosts.

Indexed as

AgingAntibodies, BacterialMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NeutrophilsOpsonizationStreptococcus pneumoniaeAdultAnimalsEnzyme ActivationFemaleHumansMiceMice, Inbred C57BLNeutrophil ActivationAntibodies, BacterialMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3agingMAPKneutrophilssignalingStreptococcus pneumoniae

Identifiers

PMID41549468
PMCPMC13564196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.